Youths with type 2 diabetes benefit from dual therapy
00:50 EDT 11 Jul 2012 | Pharmaceutical Journal
Combination therapy, with metformin plus a glitazone, achieves better glycaemic control than metformin alone in children and adolescents with type 2 diabetes (New England Journal of Medicine 2012;366:2247).
Original Article: Youths with type 2 diabetes benefit from dual therapy
More From BioPortfolio on "Youths with type 2 diabetes benefit from dual therapy"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
